IMPC phenotypes (gene matching)
C57BL/6N-Amfrem1(IMPC)Wtsi/WtsiOulu
| Status | Available to order |
| EMMA ID | EM:14466 |
| Citation information | RRID:IMSR_EM:14466 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | C57BL/6N-Amfrem1(IMPC)Wtsi/WtsiOulu |
| Alternative name | |
| Strain type | Endonuclease-mediated |
| Allele/Transgene symbol | Amfrem1(IMPC)Wtsi |
| Gene/Transgene symbol | Amfr |
Information from provider
| Provider | Wellcome Trust Sanger Institute |
| Provider affiliation | Wellcome Trust Sanger Institute |
| Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
| Phenotypic information | Potential phenotyping data in the IMPC portal |
| References | None available |
Information from EMMA
| Archiving centre | University of Oulu, Oulu, Finland |
Disease and phenotype information
MGI phenotypes (gene matching)
- abnormal liver morphology / MGI
- abnormal hepatocyte morphology / MGI
- obese / MGI
- liver inflammation / MGI
- hepatic steatosis / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating alkaline phosphatase level / MGI
- liver cirrhosis / MGI
- liver fibrosis / MGI
- cellular phenotype / MGI
- decreased circulating total protein level / MGI
- decreased lactate dehydrogenase level / MGI
- decreased circulating aspartate transaminase level / MGI
- increased liver tumor incidence / MGI
- increased physiological sensitivity to xenobiotic / MGI
- decreased circulating fructosamine level / MGI